Prevalence of genital Chlamydia trachomatis infection among young men and women in Spain. 2013

Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
Unidad de Gestión Clínica Centro de Salud de Laviana, Asturias, Spain.

BACKGROUND There are no accurate data regarding the real prevalence of Chlamydia trachomatis infection in Spain. Our aim was to determine the prevalence of C. trachomatis infections and the risk factors for acquiring them among 1,048 young (15-24 years old) inhabitants of Laviana. METHODS The study was completed in the period between 1st November 2010 and 31st December 2011. We conducted a capture strategy in the whole population, instead of only in a sample group, with a capture conducted in schools, in the local health centre, by post and by phone as a last resort. The design was based on the model used by Shafer to increase screening rates. C. trachomatis was identified by RT-PCR in urine samples. RESULTS A total of 487 sexually active people underwent the test, which implies a response rate of 59.8% of the sexually active people (target population). The prevalence was 4.1% (CI 95%: 3.1-5.8): women: 4% ( CI 95%; 2.8-6.4) and men: 4.3% (CI 95%: 2.9-7.2). The circulating genotype was the E genotype. There was an increase in the risk of C. trachomatis infection when barrier contraceptives were not routinely used OR: 4.76 (CI 95%:1.30-17.36) p<0.05. CONCLUSIONS In our study the prevalence in women resembles those found in other countries in Europe and the prevalence in men is similar to that in women. Screening for C. trachomatis infection in women would be cost-effective in Spain given the prevalence of C. trachomatis measured by this study. The use of a condom is the best preventative measure for avoiding STIs in sexually active people.

UI MeSH Term Description Entries
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D002690 Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA. Infections, Chlamydia,Chlamydia Infection,Infection, Chlamydia
D002692 Chlamydia trachomatis Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012725 Sexual Behavior Sexual activities of humans. Anal Sex,Oral Sex,Sexual Activity,Sexual Orientation,Premarital Sex Behavior,Sex Behavior,Sex Orientation,Sexual Activities,Activities, Sexual,Activity, Sexual,Behavior, Premarital Sex,Behavior, Sex,Behavior, Sexual,Orientation, Sexual,Sex, Anal,Sex, Oral
D013030 Spain Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. Balearic Islands,Canary Islands

Related Publications

Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
May 2008, Sexually transmitted diseases,
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
December 1980, Obstetrics and gynecology,
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
May 1990, International journal of STD & AIDS,
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
June 2004, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
January 1992, Scandinavian journal of infectious diseases,
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
April 2008, BMC infectious diseases,
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
August 2021, Sexually transmitted diseases,
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
January 2016, SpringerPlus,
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
May 2003, Lancet (London, England),
Carlos Fernández-Benítez, and Patricia Mejuto-López, and Luis Otero-Guerra, and Mario Juan Margolles-Martins, and Pilar Suárez-Leiva, and Fernando Vazquez, and
January 2006, Sexually transmitted diseases,
Copied contents to your clipboard!